🇺🇸 FDA
Pipeline program

Linperlisib

IIT2022067

Phase 1 small_molecule terminated

Quick answer

Linperlisib for Autoimmune Hemolytic Anemia is a Phase 1 program (small_molecule) at Xiyuan Hospital of China Academy of Chinese Medical Sciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Indication
Autoimmune Hemolytic Anemia
Phase
Phase 1
Modality
small_molecule
Status
terminated

Clinical trials